Multiple Assemblies exist for SMTL entry 6v7z
Human CD1d presenting alpha-Galactosylceramide in complex with VHH nanobody 1D22; X-RAY DIFFRACTION 2.75 Å

SMTL ID 6v7z.1 Ligands 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose; beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose; 2-acetamido-2-deoxy-beta-D-glucopyranose; N-{(1S,2R,3S)-1-[(ALPHA-D-GALACTOPYRANOSYLOXY)METHYL]-2,3-DIHYDROXYHEPTADECYL}HEXACOSANAMIDE; DI(HYDROXYETHYL)ETHER; CHLORIDE ION; SULFATE ION; beta-D-glucopyranose Polypeptides Antigen-presenting glycoprotein CD1d; Beta-2-microglobulin; Nanobody VHH ID22 Oligo-state hetero-1-1-1-mer

SMTL ID 6v7z.2 Ligands beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose; 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose; N-{(1S,2R,3S)-1-[(ALPHA-D-GALACTOPYRANOSYLOXY)METHYL]-2,3-DIHYDROXYHEPTADECYL}HEXACOSANAMIDE; SODIUM ION; DI(HYDROXYETHYL)ETHER Polypeptides Antigen-presenting glycoprotein CD1d; Beta-2-microglobulin; Nanobody VHH ID22 Oligo-state hetero-1-1-1-mer